These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2231169)

  • 21. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    Ergün S; Zheng X; Carlsöö B
    Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V; Bujia J; Negri B; Kastenbauer E
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratinization of middle ear cholesteatomas. II. A histochemical study of epidermal transglutaminase substrates.
    Broekaert D; Coucke P; Reyniers P; Marquet J
    Eur Arch Otorhinolaryngol; 1990; 247(5):318-22. PubMed ID: 1697471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
    Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
    Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of interleukin-1 in human cholesteatoma.
    Ahn JM; Huang CC; Abramson M
    Am J Otolaryngol; 1990; 11(2):71-7. PubMed ID: 2188520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
    Olszewska E; Sudhoff H
    Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
    Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
    Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on epidermal proliferation ability in cholesteatoma.
    Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
    Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localisation of basic fibroblast growth factor in cholesteatoma matrix: an immunochemical study.
    Hamed MA; Sayed RH; Shiogama K; Eltaher MA; Suzuki K; Nakata S
    J Laryngol Otol; 2019 Mar; 133(3):183-186. PubMed ID: 30808433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma.
    Shiwa M; Kojima H; Moriyama H
    J Laryngol Otol; 1998 Aug; 112(8):750-4. PubMed ID: 9850316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratinization of middle ear cholesteatomas. I. A histochemical study of epidermal transglutaminase.
    Broekaert D; Pattin C; Coucke P; De Bersaques J; Marquet J
    Eur Arch Otorhinolaryngol; 1990; 247(5):312-7. PubMed ID: 1697470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of different angiogenic factors in external auditory canal cholesteatoma.
    Naim R; Riedel F; Gotte K; Bran G; Sadick H; Gossler U; Hormann K
    Acta Otolaryngol; 2004 Jun; 124(5):563-8. PubMed ID: 15267172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V; Holly A; Bujía J; Schulz P
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical demonstration of Langerhans' cell in cholesteatoma using an antiserum against S-100 protein.
    Takahashi S; Nakano Y
    Arch Otorhinolaryngol; 1989; 246(1):48-52. PubMed ID: 2735831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.